Top
Millennium Post

Ebola vaccine trial halted for checks after joint pains

A clinical trial of an Ebola vaccine developed by Merck and NewLink has been halted temporarily as a precautionary measure after four patients complained of joint pains, the University of Geneva Hospital said on Thursday. “They are all fine and being monitored regularly by the medical team leading the study,” it said in a statement. The human safety trials, which began in Geneva on Nov. 10, are due to resume on Jan. 5 in up to 15 volunteers after checks to ensure that joint pain symptoms in hands and feet were “benign and temporary”, the hospital said. Fifty nine volunteers have been vaccinated so far.
Agencies

Agencies

Our contributor helps bringing the latest updates to you


Next Story
Share it